Abstract
Purpose: To characterize the macula microvasculature using fractal dimension (FD) in hypertensive white matter hyperintensity (WMH) participants and explore the association between the microvascular changes and serum uric acid levels.
Methods: Thirty-eight WMH participants were dementia and stroke-free, and 37 healthy controls were enrolled. Optical coherence tomographic angiography (OCTA) was used to image the superficial vascular complex (SVC), deep vascular complex (DVC), and inner vascular complex (IVC) in a 2.5-mm diameter concentric circle (excluding the foveal avascular zone FAZ). A commercial algorithm was used to quantify the complexity and density of the three capillary layers by fractal analysis.
Results: WMH participants showed significantly lower FD value in the SVC (P = 0.002), DVC (P < 0.001) and IVC (P = 0.012) macula microvasculature compared with control group. After adjusting for risk factors (hypertension, diabetes, age and gender) SVC (P = 0.035) and IVC (P = 0.030) significantly correlated with serum uric acid.
Conclusion: Serum uric acid levels are associated with microvascular changes in WMH. Fractal dimension based on OCTA imaging could help quantitatively characterize the macula microvasculature changes in WMH and may be a potential screening tool to detect serum uric acid level changes.
[http://dx.doi.org/10.1038/nrneurol.2017.16] [PMID: 28211452]
[http://dx.doi.org/10.1155/2017/4391920] [PMID: 28116308]
[http://dx.doi.org/10.1096/fj.13-247148] [PMID: 24652948]
[http://dx.doi.org/10.1161/01.HYP.0000248752.08807.4c] [PMID: 17060508]
[http://dx.doi.org/10.1080/10641963.2017.1392556] [PMID: 29182449]
[http://dx.doi.org/10.1023/A:1024600905574] [PMID: 12908717]
[http://dx.doi.org/10.1161/STROKEAHA.108.521591] [PMID: 18772442]
[http://dx.doi.org/10.1016/j.jns.2010.07.007] [PMID: 20674933]
[http://dx.doi.org/10.1159/000346606] [PMID: 23548762]
[http://dx.doi.org/10.3109/00207454.2015.1128903]
[http://dx.doi.org/10.1212/01.wnl.0000277468.10236.f1] [PMID: 17909154]
[http://dx.doi.org/10.1016/j.numecd.2010.06.005] [PMID: 20708913]
[http://dx.doi.org/10.1038/nrneurol.2012.227] [PMID: 23165340]
[http://dx.doi.org/10.1001/jamaophthalmol.2014.3616] [PMID: 25317632]
[http://dx.doi.org/10.1016/j.ajoc.2016.09.007] [PMID: 29260054]
[http://dx.doi.org/10.1111/j.1469-7580.2005.00395.x] [PMID: 15817102]
[http://dx.doi.org/10.1002/brb3.1521]
[http://dx.doi.org/10.1111/j.1747-4949.2012.00865.x] [PMID: 22988830]
[http://dx.doi.org/10.1007/s10072-017-3234-9] [PMID: 29302814]
[PMID: 9368798]
[http://dx.doi.org/10.1109/TMI.2020.3042802] [PMID: 33284751]
[http://dx.doi.org/10.1038/srep42201] [PMID: 28186181]
[http://dx.doi.org/10.3389/fneur.2021.724946] [PMID: 34630300]
[http://dx.doi.org/10.1152/ajpheart.00201.2016] [PMID: 27923786]
[http://dx.doi.org/10.1038/s41598-019-42534-x]
[http://dx.doi.org/10.1161/STROKEAHA.113.001741] [PMID: 23715958]
[http://dx.doi.org/10.3988/jcn.2020.16.1.19] [PMID: 31942754]
[http://dx.doi.org/10.1212/WNL.0000000000003080] [PMID: 27511186]
[http://dx.doi.org/10.1161/STROKEAHA.116.014998] [PMID: 27729577]
[http://dx.doi.org/10.1167/iovs.18-25341] [PMID: 30326071]
[http://dx.doi.org/10.1186/s12886-021-02143-7] [PMID: 35168582]
[http://dx.doi.org/10.3389/fneur.2020.00521] [PMID: 32714262]
[http://dx.doi.org/10.1177/1759091414562107] [PMID: 25504540]
[http://dx.doi.org/10.1167/iovs.11-7276] [PMID: 21791593]
[http://dx.doi.org/10.1002/brb3.2240]
[http://dx.doi.org/10.1098/rstb.2014.0195]
[http://dx.doi.org/10.1038/srep18291]
[http://dx.doi.org/10.1093/brain/awq127] [PMID: 20519327]
[http://dx.doi.org/10.1186/s13195-020-00638-x]